Effects of administration of antioxidants in acute intermittent porphyria

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 35, Issue 6, 1997, Pages 427-433

  Thunell, Stig ^a,d   Andersson, Dan ^b   Harper, Pauline ^c   Henrichson, Ann ^b   Floderus, Ylva ^a   UlfLindh, ^a  

^a Porphyria Centre Sweden   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c Department of Radiation Sciences ^*  (Sweden)

^d ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARNITINE; FREE RADICAL; MANNITOL; PORPHYRIN; SELENIUM; SUPEROXIDE DISMUTASE;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; ANTIOXIDANTS; CALCIUM; DRUG THERAPY, COMBINATION; ERYTHROCYTES; FEMALE; FREE RADICALS; GRANULOCYTES; HUMANS; MALE; MANGANESE; OXIDATIVE STRESS; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRINS; TRACE ELEMENTS;

EID: 0030745145     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGrawHill 1995:2103-59.
2. Moore MR, McColl KEL, Rimington C, Goldberg A. Pathogenesis of the neuropathy of acute porphyria. In: Wintrobe MM, editor. Disorders of porphyrin metabolism. New York and London: Plenum Publishing Corporation 1987:119-37.
3. Demasi M, Penatti CAA, DeLucia R, Bechara EJH. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatrie manifestations in porphyrias. Free Radie Biol Med 1996; 20:291-9.
4. Juknat AA, Kotler ML, Batlle AMC. High 5-aminolevulinic acid uptake in rat cerebral cortex: effect on porphyrin biosynthesis. Comp Biochem Physiol 1995; 111C:143-50.
5. Thunell S, Andersson C, Carlmark B, Floderus Y, Grönqvist SO, Harper P, et al. Markers for vulnerability in acute porphyria. A hypothesis paper. Eur J Clin Chem Clin Biochem 1995;33:179-94.
6. Andersson C, Thunell S, Floderus Y, Forsell C, Lundin G, Anvret M, et al. Diagnosis of acute intermittent porphyria in Northern Sweden: an evaluation of mutation analysis and biochemical methods. J Int Med 1995; 237:301-8.
7. Mustajoki P, Tenhunen R. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-1-synthase activity. Eur J Clin Invest 1995; 15:281-4.
8. Mauzerall D, Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956; 219:435-46.
9. Davis JR, Andelman SL. Urinary delta-aminolevulinic acid (ALA) levels in lead poisoning. I. A modified method for the rapid determination of urinary delta-aminolevulinic acid using disposable ion-exchange Chromatograph columns. Arch Environ Health 1967; 15:53-9.
10. Doss M, Schmidt A. Rapid determination of urinary total porphyrins by ion exchange chromatography. Z Klin Chem Klin Biochem 1971; 9:415-8.
11. Lindh U, Johansson E. Trace-elements determination in individual peripheral blood cells and possible diagnostic applications. Biol Trace Element Res 1987; 12:351-62.
12. Halliwell B, Gutteridge J, Cross C. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
13. Hao Chen, Al L. Protection by vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, betacarotene, canthaxanthin, and ( + )-catechin against oxidative damage to liver slices measured by oxidized heme proteins. Free Rad Biol Med 1994; 16:437-44.
14. Wider de Xifra EA, Batlle AM del C, Stella AM, Malamud S. Acute intermittent porphyria - another approach to therapy. Int J Biochem 1980; 12:819-922.
15. Niki E. Antioxidant compounds. In: Davies, editor. Oxidative damage and repair. Chemical biological and medical aspects. New York: Pergamon Press 1991; 57-64.
16. Machlin I, Gabriel E. Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E. Ann NY Acad Sci 1982; 393:48-59.
17. Menkes MS, Comstock G, Vuilleumier Helsing KJ, Rider A, Brookmeyer R. Serum beta-carotene, vitamins A and selenium and the risk of lung cancer. N Engl J Med 1986; 315:1250-4.
18. Blot W, Li J-Y, Tailor P, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian China: supplementation with specific vitamin/mineral combination, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85:1483-92.
19. Uden S, Bilton D, Nathan L, Hunt LP, Mains C, Braganza JM. Antioxidant therapy for recurrent pancreatitis; placebo-controlled trial. Aliment Pharmacol Therap 1990; 4:357-71.